Souhaitez-vous accéder aux communiqués récents ?

TEL AVIV, March 09, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative...

TEL AVIV, March 09, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative...

neffy delivers $72.2 million of U.S. net product revenue in first full year Intranasal epinephrine platform advances with Phase 2b CSU data expected mid-2026 Strong balance sheet of $245.0 million...

FluffCo Luxury Hotel Pillow marketing claims, materials, pricing, and hotel-quality positioning evaluated in latest 2026 consumer report.

Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial...

VIENNA, Austria, March 05, 2026 (GLOBE NEWSWIRE) -- Easy to transport, featuring compact size and high-quality images, developed to revolutionise and facilitate the work of interventional radiologists...

Dublin, March 05, 2026 (GLOBE NEWSWIRE) -- The "Blood Collection Devices Market by Product (Tubes (Plasma (EDTA, Heparin), Serum), Needles & Syringes, Blood Bags, Monitors), Method (Manual,...

ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis.

Full year 2025 business update and financial results conference call to be held March 12 at 4:30 p.m. ET Stockholder fireside chat to be held on March 13 at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif.,...

New York City, NY, March 03, 2026 (GLOBE NEWSWIRE) -- TestoPrime Testostone Booster for Men Over 50 Facts Product: TestoPrime Natural Testosterone BoosterAccreditation: Clinicians' Choice —...